Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134903) titled 'investigator-initiated trial (IIT) to evaluate the safety and efficacy of zolpidem tablets in adult with insomnia disorder' on Oct. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University Sixth Hospital ( Institute of Mental Health )
Condition:
Insomnia disorder
Intervention:
Intervention group:Zolpidem tartrate tablets: take 1 tablet (10 mg) orally once before going to bed each night, for a total of 6 days.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-23
Target Sample Size: Intervention group:8;Placebo group:4;
Countries of ...